RE: new appointment RNS13 Oct 2021 08:33
From Linkedin,
About,
Senior pharma executive with over 30 years’ experience predominantly in global regulatory affairs, but including clinical research and commercial, gained in large and small Pharma as well as novel service companies.
Proven expertise at deriving and delivering regulatory affairs strategy for project portfolios across the lifecycle from late research/preclinical, through marketing authorisation to post-approval, in multiple therapeutic areas (including anti-infective, oncology, CNS and cardiovascular; biologics and NMEs,) and regions (EU, US and Japan). Particular expertise in leveraging regulatory strategy as a core business driver to accelerate patient access to innovative therapies.
Experienced industry leader and Board member in a variety of business models, including internal and external global resource management, financial management and HR. Co-founder and executive director of a global drug development services company (PLC).